Disturbances of sleep continuity in women during the menopausal transition.
OBJECTIVE
The objective of the study was to evaluate the prevalence of sleep continuity disorders in women during menopausal transition, to evaluate the relationship between disturbances of sleep continuity and the severity of menopausal syndrome and the occurrence of various symptoms of this syndrome, as well as to evaluate the association between the presence of sleep disturbances and serum concentrations of gonadotropins, prolactin and sex hormones.


METHODS
Consecutive 140 women (mean age 54.4 ± 4.7 years) searching for the treatment in the Clinic for Gynaecological Endocrinology who reported symptoms of menopausal syndrome were investigated. The type and severity of disturbances of sleep continuity were evaluated using a survey based on the sleep related questions from Hamilton Depression Rating Scale. The severity of symptoms of menopausal syndrome was assessed using the Kupperman Index. The concentration of the following hormones in blood serum was tested: FSH, LH, 17β-estradiol, PRL, total testosterone, DHEAS and SHBG.


RESULTS
Disturbances of sleep continuity were a prevalent complaint in the studied group of women. Difficulties in falling asleep were found in 57.8% of women, difficulties in maintaining sleep in 70%, waking up too early in 60.7%. The severity of all three types of sleep continuity disturbances was related to the severity of menopausal syndrome as measured with Kupperman Index (Spearman correlation coefficient r = 0.63, r = 0.61, r = 0.52, respectively; p < 0.001). Difficulties in maintaining sleep were negatively correlated with the concentration of FSH (r = - 0.19; p < 0.05), 17β-estradiol (r = - 0.19; p < 0.05) and SHBG (r = - 0.18; p < 0.05), difficulties in falling asleep negatively correlated with the concentration of 17β-estradiol in the blood serum (r = - 0.19; p < 0.05).


CONCLUSIONS
Sleep continuity disturbances are frequently reported by women during the menopausal transition. Interventions aimed at reducing the symptoms of menopausal syndrome should be considered as important action to improve sleep quality in this population of patients.
Department of Gynecological Endocrinology, Poznan University of Medical Sciences.
Radosław
R
Słopień
Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw.
Adam
A
Wichniak
Department of Gynecological Surgery, Poznan University of Medical Sciences.
Michał
M
Pawlak
Department of Child and Adolescent Psychiatry, Poznan University of Medical Sciences.
Agnieszka
A
Słopień
Department of Gynecological Endocrinology, Poznan University of Medical Sciences.
Alina
A
Warenik-Szymankiewicz
Department of Gynecological Surgery, Poznan University of Medical Sciences.
Stefan
S
Sajdak
D000328:Adult; D000368:Aged; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D008593:Menopause / Q000097:blood / Q000502:physiology*; D008875:Middle Aged; D015995:Prevalence; D011388:Prolactin / Q000097:blood; D012720:Severity of Illness Index; D012890:Sleep / Q000502:physiology*; D012893:Sleep Wake Disorders / Q000097:blood* / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology*; D013739:Testosterone / Q000097:blood
D013739:Testosterone; D004958:Estradiol; D011388:Prolactin; D005640:Follicle Stimulating Hormone
climacteric syndrome; disturbances of sleep continuity; menopause